PRSS1 and autoimmune pancreatitis: ELISA testing based on recombinant antigens revealed significantly increased levels at 1/600 serum dilution, particularly against trypsinogen PRSS1 in AIP patients compared to non-AIP chronic pancreatitis patients or normal controls.